Stock info Omeros Corp | Filter  Basic-Info

Omeros Corp

The company mostly operates in the pharmaceutical sector. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a good year for Omeros Corp investors

Over the period from December 2015 till December 2016 the stock lost around 21 percent. Omeros Corp' stock rose the past 5 years at around 177 percent. Omeros Corp's revenues between 2011 and 2015 were very volatile and moved between 6,02 million dollars and 13,51 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between -28,55 million dollars and -75,1 million dollars.

The American company didn't pay out any dividends (in the past 5 years). Omeros Corp raised it's dividends per share each year in the past 5 years. Based on the raising dividend payments Omeros Corp can be seen as a kind of dividend aristocrat.

Omeros Corp' balance mostly financed with equity

At the end of 2015 the American company's balance sheet was worth 49 million dollars. 75,23 million dollars (153,53 percent of the total balance sheet) was financed by debt. The American company's price/earnings-ratio was -13. So the market valued the stock at -13 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 572,79 million dollars. At the end of 2015 the American company had around 37,56 million stocks listed.

All Omeros Corp's financial reports are available here. More information about Omeros Corp can be found it's website. .